thiazoles has been researched along with Measles, German in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adebayo, A; Hautala, T; Icenogle, J; Perelygina, L; Seppänen, M; Sullivan, KE | 1 |
| Buchbinder, D; Deripapa, E; Dorsey, MJ; Eloit, M; Hauck, F; Hautala, T; Icenogle, J; Moshous, D; Perelygina, L; Sullivan, KE; Uriarte, I | 1 |
2 other study(ies) available for thiazoles and Measles, German
| Article | Year |
|---|---|
Inhibition of rubella virus replication by the broad-spectrum drug nitazoxanide in cell culture and in a patient with a primary immune deficiency.
Topics: A549 Cells; Animals; Antigens, Viral; Antiviral Agents; Cell Survival; Chlorocebus aethiops; Female; Granuloma; Human Umbilical Vein Endothelial Cells; Humans; Immunologic Deficiency Syndromes; Inhibitory Concentration 50; Nitro Compounds; Protein Transport; Rubella; Rubella virus; Skin; Thiazoles; Treatment Outcome; Vero Cells; Virus Replication | 2017 |
Outcomes for Nitazoxanide Treatment in a Case Series of Patients with Primary Immunodeficiencies and Rubella Virus-Associated Granuloma.
Topics: Adolescent; Child; Child, Preschool; Female; Granuloma; Humans; Immunologic Deficiency Syndromes; Infant; Male; Nitro Compounds; Retrospective Studies; Rubella; Rubella virus; T-Lymphocytes; Thiazoles; Vaccination | 2019 |